US Stock MarketDetailed Quotes
SYBX Synlogic
- 1.7900
- -0.0400-2.19%
Close May 10 16:00 ET
20.81MMarket Cap-203P/E (TTM)
1.8300High1.7900Low7.12KVolume1.8300Open1.8300Pre Close12.90KTurnover0.32%Turnover RatioLossP/E (Static)11.63MShares9.900052wk High0.49P/B4.02MFloat Cap1.550052wk Low--Dividend TTM2.25MShs Float345.0000Historical High--Div YieldTTM2.19%Amplitude1.5500Historical Low1.8110Avg Price1Lot Size
About Synlogic Company
Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.
Company Profile
SymbolSYBX
Company NameSynlogic
Listing DateOct 1, 2015
Issue Price7.00
Founded2007
CEOMr. Antoine Awad
MarketNASDAQ
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address301 Binney Street,Suite 402
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-401-9975
Websitehttp://www.synlogictx.com
Company Executives
- Name
- Position
- Salary
- Antoine Awad
- Principal Executive Officer
- 876.33K
- Mary Beth Dooley
- Head of Finance, Principal Financial Officer and Principal Accounting Officer
- --
- Dr. Peter Barrett,PhD
- Chairman of the Board
- 103.52K
- James Flynn
- Director
- --
- Nick Leschly
- Independent Director
- 67.02K
- Edward T. Mathers
- Independent Director
- 67.02K
- Richard P. Shea
- Independent Director
- 77.02K
- Michael T. Heffernan, R.Ph.
- Independent Director
- 77.52K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg